Navigation Links
Seal Shield Ships New SILVER SEAL(TM) Washable, Antimicrobial Keyboard
Date:2/12/2008

New Keyboard aimed at reducing cross contaminations including Norovirus and

MRSA

JACKSONVILLE, Fla., Feb. 12 /PRNewswire/ -- Seal Shield LLC announced that it has begun shipping the new SILVER SEAL(TM) Washable, Antimicrobial Keyboard. According to the company, the SILVER SEAL(TM) Keyboard is the world's first computer keyboard to be fully submersible, dishwasher safe, and manufactured from SILVER SEAL(TM) Antimicrobial plastic. The SILVER SEAL(TM) Keyboard has been created to help reduce the risk of cross contaminations, including Norovirus and the "superbug," MRSA. The SILVER SEAL(TM) Keyboard is the Antimicrobial version of the company's best selling, SEAL SHIELD(TM) Medical Grade Washable Keyboard (Patent Pending), which was introduced last year.

Norovirus stomach flu is commonly contracted on cruise ships, in schools, workplaces and hospitals. It can be life-threatening to infants, seniors or those with weakened immune systems. The U.S. Center for Disease Control (CDC) research on a 2007 norovirus outbreak at an elementary school revealed computer keyboards and mice were a source of transmission.

This year over 2 million patients will contract an infection while seeking treatment in a US hospital. Of those, close to 100,000 people will die, making hospital acquired infections a Top 10 killer of Americans. Complicating this epidemic, the antibiotic resistant "superbug," MRSA, has emerged in hospitals and schools worldwide. Computer keyboards have been shown to be a primary culprit for such cross contaminations.

According to University of Arizona scientist, Dr. Charles Gerba, "the keyboard has some 10 million germs." Dr. Gerba also stated that "the keyboard has about 400 times more germs than the average toilet seat."

"The new Silver Seal Keyboard is the best in class, infection control keyboard on the market. It is manufactured with a true type design for maximum comfort and ease of use,
'/>"/>

SOURCE Seal Shield LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Alvarado Hospital Files Countersuit Against Blue Shield
2. BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank
3. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
4. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
5. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
6. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
7. Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency
8. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
9. Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness
10. Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
11. Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ngland register the lowest number of early deaths ...ls of obesity and the longest life expectancy. By...s the lowest life expectancy for men. Near neighbo...men. Those in both cities live, on average, near...
...ng the link between levels of urate in the blood a...the Harvard School of Public Health (HSPH) have fo...ted with a reduced risk of the disease. Urate is...ugh high levels can lead to gout, urate might also...
...er for three years. Circuit Judge Weber McCraw, wh...r the option of serving some of her sentence in a...nnessee preacher told the Jurors presiding over he... shot her husband. She had been suffering domestic...
...patients who have recently suffered a major heart ...rom their own bone marrow during routine coronary...her the stem cells will repair heart muscle cells ...ing late scar formation and hence impaired heart c...
Other Medicine News:Health News:Southern England Far Healthier Than the North 2Health News:Urate Reduces the Risk of Parkinsons Disease 2Health News:Domestic Abuse Led Wife Killing Her Preacher Husband 2Health News:A New Milestone in Stem Cell Research 2
(Date:8/27/2008)...tients in the VELCADE, melphalan and prednisone ar... well as a 30 percent complete response -, CAMBRI...e Takeda,Oncology Company today announced the publ...d, Phase III VISTA(1) trial in this week,s edition...ts showed a significant survival,benefit and a 30 ...
(Date:8/27/2008)...First Phase 3 data, from BLISS-52 trial, expected ...LISS-76, expected by fall 2009 -, ROCKVILLE, Md.,...iences, Inc. (Nasdaq: HGSI ) today announced it h...S-76, the second of two pivotal Phase 3,randomized... patients with,active systemic lupus erythematosus...
(Date:8/26/2008)...IANAPOLIS, Aug. 26 /- Semafore Pharma...national Congress on Targeted Therapies,in Cancer ...ovel,multi-targeted kinase inhibitors that demonst...l studies., A novel and proprietary molecular sca...ing allowing for the design of pan-PI3 kinase inhi...
(Date:8/26/2008)...LO PARK, Calif., Aug. 26 /-... the positive one-year follow-up data,from the CUS...e of the,peer-reviewed journal, EuroIntervention. ...tella, M.D., of University Medical Center Utrecht,...II Investigators from 13 clinical,sites across Eur...
Breaking Medicine Technology:New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Blood pressure drug telmisartan shows powerful activity against stroke 1570 1Blood pressure drug telmisartan shows powerful activity against stroke 1570 2Blood pressure drug telmisartan shows powerful activity against stroke 1570 3Ireland Cancer Center researchers advance stem cell gene therapy 1565 1Ireland Cancer Center researchers advance stem cell gene therapy 1565 2Ireland Cancer Center researchers advance stem cell gene therapy 1565 3Wind power explored off Californias coast 1563 1Wind power explored off Californias coast 1563 2Wind power explored off Californias coast 1563 3Wind power explored off Californias coast 1563 4Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 1Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 2Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 3Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 4
The PachPen uses state-of-the-art waveform analysis and a probe that samples at a 65MHz rate to obtain precise readings. The PachPen stores and averages nine measurements and calculates IOP correctio
...ailable as both regular and filter tips. Sterilize...re efficient sterilization and are delivered with ...e of irradiation. Sterilized Diamond Tips are read...k Diamond Tips are wrapped in medical device quali...
300 L, Bulk Recommended for 250 and 300 L pipettes.
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio
Medicine Products: